TY - JOUR
T1 - Microrobots
T2 - A new era in ocular drug delivery
AU - Fusco, Stefano
AU - Ullrich, Franziska
AU - Pokki, Juho
AU - Chatzipirpiridis, George
AU - Özkale, Berna
AU - Sivaraman, Kartik M.
AU - Ergeneman, Olgaç
AU - Pané, Salvador
AU - Nelson, Bradley J.
N1 - Publisher Copyright:
© 2014 Informa UK, Ltd.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Introduction: Ocular microrobots have the potential to change the way in which we treat a variety of diseases at the anterior and the posterior segments of the eye. Wireless manipulation and positioning of drug delivery magnetic millimeter and submillimeter platforms into the eye constitute a potential route for minimally invasive targeted therapy. However, the field is still in its infancy and faces challenges related to the fabrication, control an interaction with complex biological environments.Areas covered: This review briefly introduces the complex anatomy and physiology of the eye, which renders limitations to the current treatments of ocular diseases. The topical administration of eye drops, intravitreal injections and drug delivery implants is briefly mentioned together with their drawbacks. The authors also analyze the minimally invasive microrobotic approach as an alternative method and report the recent advancements in the fabrication, control, manipulation and drug delivery.Expert opinion: Although microrobotics is a young field, a significant amount of work has been developed to face different challenges related to the minimally invasive manipulation of microdevices in the eye. Current research is already at the state of in vivo testing for systems and their biocompatibility. It is expected that the general concepts acquired will soon be applied for specific interventions, especially for posterior eye pathologies.
AB - Introduction: Ocular microrobots have the potential to change the way in which we treat a variety of diseases at the anterior and the posterior segments of the eye. Wireless manipulation and positioning of drug delivery magnetic millimeter and submillimeter platforms into the eye constitute a potential route for minimally invasive targeted therapy. However, the field is still in its infancy and faces challenges related to the fabrication, control an interaction with complex biological environments.Areas covered: This review briefly introduces the complex anatomy and physiology of the eye, which renders limitations to the current treatments of ocular diseases. The topical administration of eye drops, intravitreal injections and drug delivery implants is briefly mentioned together with their drawbacks. The authors also analyze the minimally invasive microrobotic approach as an alternative method and report the recent advancements in the fabrication, control, manipulation and drug delivery.Expert opinion: Although microrobotics is a young field, a significant amount of work has been developed to face different challenges related to the minimally invasive manipulation of microdevices in the eye. Current research is already at the state of in vivo testing for systems and their biocompatibility. It is expected that the general concepts acquired will soon be applied for specific interventions, especially for posterior eye pathologies.
KW - Eye
KW - Functional coatings
KW - Magnetic manipulation
KW - Microrobots
UR - http://www.scopus.com/inward/record.url?scp=84911479484&partnerID=8YFLogxK
U2 - 10.1517/17425247.2014.938633
DO - 10.1517/17425247.2014.938633
M3 - Review article
C2 - 25001411
AN - SCOPUS:84911479484
SN - 1742-5247
VL - 11
SP - 1815
EP - 1826
JO - Expert Opinion on Drug Delivery
JF - Expert Opinion on Drug Delivery
IS - 11
ER -